Lilly Insulin Glargine Versus Lantus((R)) in Insulin-Naive and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)

Pollom, RK; Ilag, LL; Lacaya, LB; Morwick, TM; Carrasquillo, RO

Pollom, RK (reprint author), Eli Lilly & Co, Indianapolis, IN 46285 USA.

DIABETES THERAPY, 2019; 10 (1): 189

Abstract

IntroductionThis study compared the efficacy and safety of similar U-100 insulin glargine products, namely, Lilly insulin glargine (LY IGlar; Basaglar......

Full Text Link